Contents
Current Pharmaceutical Design, Volume 10 - Number 19
A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials
, 10(19): 2289 - 2298Richard Piekarz and Susan Bates
DOI: 10.2174/1381612043383980
Membrane Disrupting Lytic Peptides for Cancer Treatments
, 10(19): 2299 - 2310Carola Leuschner and William Hansel
DOI: 10.2174/1381612043383971
Small Molecule Toxins Targeting Tumor Receptors
, 10(19): 2311 - 2334Marcin Dyba, Nadya I. Tarasova and Christopher J. Michejda
DOI: 10.2174/1381612043384024
Role of Progastrins and Gastrins and Their Receptors in GI and Pancreatic Cancers: Targets for Treatment
, 10(19): 2345 - 2358William Rengifo-Cam and Pomila Singh
DOI: 10.2174/1381612043383999
The Urokinase Receptor as a Potential Target in Cancer Therapy
, 10(19): 2359 - 2376John Romer, Boye Schnack Nielsen and Michael Ploug
DOI: 10.2174/1381612043383962
An Expanding Appreciation of the Role Chemokine Receptors Play in Cancer Progression
, 10(19): 2377 - 2389O.M. Zack Howard and Carole L. Galligan
DOI: 10.2174/1381612043383935
The MEP Pathway: A New Target for the Development of Herbicides, Antibiotics and Antimalarial Drugs
, 10(19): 2391 - 2400M. Rodriguez-Concepcion
DOI: 10.2174/1381612043384006
The Therapeutic Role of Taurine in Ischaemia-Reperfusion Injury
, 10(19): 2401 - 2410R. Kingston, C. J. Kelly and P. Murray
DOI: 10.2174/1381612043384015
Webmaster Contact: info@benthamscience.net